Reportlinker Adds Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Dec 08, 2010, 12:56 ET from Reportlinker

NEW YORK, Dec. 8, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

http://www.reportlinker.com/p0336537/Orthobiologics---Global-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016.html

Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Summary

GlobalData's new report, "Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" provides key data, information and analysis on the global orthobiologics market. The report provides market landscape, competitive landscape and market trends information the orthobiologics market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include Bone Allografts, Bone Graft Substitutes (Synthetic Bone Graft Substitutes, and bone morphogenic proteins), Bone Growth Stimulators, Demineralized Bone Matrix (DBM), and Viscosupplementation.

- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within orthobiologics market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Medtronic, Genzyme Corporation, DePuy, Synthes, Smith & Nephew, and Stryker Corporation.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the orthobiologics market globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next being thing in the orthobiologics market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global orthobiologics market and the factors shaping it.

1 Table of contents 3

1.1 List of Tables 6

1.2 List of Figures 8

2 Introduction: Orthobiologics 9

2.1 GlobalData Report Guidance 9

3 Overview: Orthobiologics 10

3.1 Applications of Orthobiologics 11

4 Global Orthobiologics Market Characterization 12

4.1 Global Orthobiologics Market, Revenue ($m), Historic, 2002 – 2009 12

4.2 Global Orthobiologics Market, Revenue ($m), Forecast, 2009 – 2016 13

4.3 Global Orthobiologics, Market Dynamics 14

4.3.1 Orthobiologics, Market Drivers 15

4.3.2 Orthobiologics, Market Restraints 17

5 Global Orthobiologics Market: Segment Analysis 18

5.1 Global Bone Graft Substitutes Market, Revenue ($m), Historic, 2002 – 2009 18

5.2 Global Bone Graft Substitutes Market, Revenue ($m), Forecast, 2009 – 2016 19

5.2.1 Bone Graft Substitutes, Market Drivers 20

5.2.2 Bone Graft Substitutes, Market Restraint: Safety Concerns over Bone Morphogenetic Protein (BMP) in Spinal Fusion Surgeries and High Cost is Slowing the Adoption 20

5.3 Global Viscosupplementation Market, Revenue ($m), Historic, 2002 – 2009 21

5.4 Global Viscosupplementation Market, Revenue ($m), Forecast, 2009 – 2016 22

5.4.1 Viscosupplementation, Market Drivers 23

5.4.2 Viscosupplementation, Market Restraint: Pricing Challenges to Continue to Plague the Viscosupplementation Market 23

5.5 Global DBM Market, Revenue ($m), Historic, 2002 – 2009 24

5.6 Global DBM Market, Revenue ($m), Forecast, 2009 – 2016 25

5.6.1 DBM, Market Drivers 26

5.6.2 DBM, Market Restraint: Several Potential Disadvantages such as potential to transmit human immunodeficiency virus may Act as Restraint for Market Growth 26

5.7 Global Bone Growth Stimulators Market, Revenues ($m), Historic, 2002 – 2009 27

5.8 Global Bone Growth Stimulators Market, Revenues ($m), Forecast, 2009 – 2016 28

5.8.1 Bone Growth Stimulators, Market Driver: Increasing Number of Fractures due to Ageing is Expected to Drive the Market Growth for Bone Growth Stimulators 28

5.8.2 Bone Growth Stimulators, Market Restraint: Lack of Exact Knowledge about the Mechanism of Action for These Devices and Lack of Studies in Specific Patient Groups will Restrict their Adoption 29

5.9 Global Bone Allografts Market, Revenue ($m), Historic, 2002-2009 29

5.10 Global Bone Allografts Market, Revenue ($m), Forecast, 2009-2016 30

5.10.1 Bone Allografts, Market Drivers: The advantages offered by allografts over autografts - the elimination of second surgery to drive the market 31

5.10.2 Bone Allografts, Market Restraints: Various Complications Associated with Bone Allografts is Restraining their Adoption 31

6 Global Orthobiologics Market, Segment Analysis, 2002-2016 32

6.1 Global Orthobiologics Market, Revenue ($m), By Country, 2002-2016 33

6.1.1 US Orthobiologics Market, Revenue ($m), Historic, 2002-2009 33

6.1.2 US Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 34

6.1.3 Canada Orthobiologics Market, Revenue ($m), Historic, 2002-2009 35

6.1.4 Canada Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 36

6.1.5 Germany Orthobiologics Market, Revenue ($m), Historic, 2002-2009 37

6.1.6 Germany Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 38

6.1.7 UK Orthobiologics Market, Revenue ($m), Historic, 2002-2009 39

6.1.8 UK Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 40

6.1.9 France Orthobiologics Market, Revenue ($m), Historic, 2002-2009 41

6.1.10 France Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 42

6.1.11 Spain Orthobiologics Market, Revenue ($m), Historic, 2002-2009 43

6.1.12 Spain Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 44

6.1.13 Italy Orthobiologics Market, Revenue ($m), Historic, 2002-2009 45

6.1.14 Italy Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 46

6.1.15 Japan Orthobiologics Market, Revenue ($m), Historic, 2002-2009 47

6.1.16 Japan Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 48

6.1.17 China Orthobiologics Market, Revenue ($m), Historic, 2002-2009 49

6.1.18 China Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 50

6.1.19 India Orthobiologics Market, Revenue ($m), Historic, 2002-2009 51

6.1.20 India Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 52

6.1.21 Australia Orthobiologics Market, Revenue ($m), Historic, 2002-2009 53

6.1.22 Australia Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 54

6.1.23 Brazil Orthobiologics Market, Revenue ($m), Historic, 2002-2009 55

6.1.24 Brazil Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 56

7 Global Orthobiologics Market: Strategic Competitive Assessment 57

7.1 Medtronic Inc. 58

7.1.1 Overview: 58

7.2 Genzyme Corporation 59

7.2.1 Overview 59

7.3 Depuy, Inc.(Johnson & Johnson) 60

7.3.1 Overview 60

7.4 Synthes, Inc. 61

7.4.1 Overview 61

7.5 Smith & Nephew Plc 62

7.5.1 Overview 62

7.6 Stryker 63

7.6.1 Overview 63

7.7 Orthofix International N.V 64

7.7.1 Overview 64

8 Key Orthobiologics in the Market 65

8.1 Bone Graft Substitutes 65

8.1.1 InFUSE (Medtronic, Inc.) 65

8.1.2 OP 1 Putty (Stryker) 65

8.1.3 chronOS (Synthes) 65

8.1.4 Healos Bone Graft Replacement 66

8.2 Viscosupplementation 66

8.2.1 Synvisc-one 66

8.2.2 SUPARTZ 67

8.3 DBM 67

8.3.1 Optium DBM 67

8.3.2 DBX 67

8.3.3 VIAGRAF 68

8.4 Bone Growth Stimulators 68

8.4.1 Exogen 68

8.4.2 Physio-Stim 68

8.5 Bone Allograft 69

8.5.1 Allograft TLIF 69

8.5.2 Allograft PL 69

8.5.3 Trinity Evolution 69

9 Global Orthobiologics Market: Strategic Pipeline Assessment 70

9.1 Orthobiologics Market: Pipeline Products Summary 70

9.2 Profiles of Promising Products Under Clinical Development: 72

9.2.1 Synthetic Bone Graft Substitutes 72

9.2.2 BMP 74

9.2.3 Bone Growth Stimulators 75

9.2.4 Bone Allograft 76

9.2.5 Viscosupplementation 77

9.2.6 DBM 78

9.3 List of Pipeline Products 78

9.3.1 Pipeline Product Summary 78

10 Global Orthobiologics Market: Strategic Deals Analysis 85

10.1 Key Deals 87

10.1.1 Medtronic to Acquire Osteotech 87

10.1.2 Landec Acquires Lifecore Biomedical 87

10.1.3 Baxter International Completes Acquisition Of ApaTech 87

10.1.4 TiGenix Completes Acquisition Of OrthoMimetics 88

10.1.5 NuVasive Invests In Progentix Orthobiology 88

10.1.6 Kinetic Concepts Acquires LifeCell 88

10.1.7 Pioneer Surgical Acquires Angstrom Medica 89

10.1.8 Pioneer Surgical Technology Acquires Encelle 89

10.1.9 Orthofix Acquires Blackstone Medical 89

11 Appendix 90

11.1 Definitions 91

11.1.1 Orthobiologics 91

11.2 Acronyms 91

11.3 References 92

11.4 Research Methodology 92

11.5 Secondary Research 92

11.6 Primary Research 92

11.7 Models 93

11.8 Forecasts 93

11.9 Expert Panels 93

11.10 GlobalData Consulting 94

11.11 Contact Us 94

11.12 Disclaimer 941.1 List of Tables

Table 1: Orthobiologics Market, Global, Revenue ($m), 2002–2009 12

Table 2: Orthobiologics Market, Global, Revenue ($m), 2009–2016 14

Table 3: Bone Graft Substitutes Market, Global, Revenue ($m), 2002–2009 18

Table 4: Bone Graft Substitutes Market, Global, Revenue ($m), 2009–2016 19

Table 5: Viscosupplementation Market, Global, Revenue ($m), 2002–2009 21

Table 6: Viscosupplementation Market, Global, Revenue ($m), 2009–2016 22

Table 7: DBM Market, Global, Revenue ($m), 2002–2009 24

Table 8: DBM Market, Global, Revenue ($m), 2009–2016 25

Table 9: Bone Growth Stimulators Market, Global, Revenue ($m), 2002–2009 27

Table 10: Bone Growth Stimulators Market, Global, Revenue ($m), 2009–2016 28

Table 11: Bone Allografts Market, Global, Revenue ($m), 2002–2009 29

Table 12: Bone Allografts Market, Global, Revenue ($m), 2009–2016 30

Table 13: Orthobiologics Market, Global, Segment Analysis, 2002 – 2016 32

Table 14: Orthobiologics Market, US, Revenue ($m), 2002-2009 33

Table 15: Orthobiologics Market, US, Revenue ($m), 2009-2016 34

Table 16: Orthobiologics Market, Canada, Revenue ($m), 2002-2009 35

Table 17: Orthobiologics Market, Canada, Revenue ($m), 2009-2016 36

Table 18: Orthobiologics Market, Germany, Revenue ($m), 2002-2009 37

Table 19: Orthobiologics Market, Germany, Revenue ($m), 2009-2016 38

Table 20: Orthobiologics Market, UK, Revenue ($m), 2002-2009 39

Table 21: Orthobiologics Market, UK, Revenue ($m), 2009-2016 40

Table 22: Orthobiologics Market, France, Revenue ($m), 2002-2009 41

Table 23: Orthobiologics Market, France, Revenue ($m), 2009-2016 42

Table 24: Orthobiologics Market, Spain, Revenue ($m), 2002-2009 43

Table 25: Orthobiologics Market, Spain, Revenue ($m), 2009-2016 44

Table 26: Orthobiologics Market, Italy, Revenue ($m), 2002-2009 45

Table 27: Orthobiologics Market, Italy, Revenue ($m), 2009-2016 46

Table 28: Orthobiologics Market, Japan, Revenue ($m), 2002-2009 47

Table 29: Orthobiologics Market, Japan, Revenue ($m), 2009-2016 48

Table 30: Orthobiologics Market, China, Revenue ($m), 2002-2009 49

Table 31: Orthobiologics Market, China, Revenue ($m), 2009-2016 50

Table 32: Orthobiologics Market, India, Revenue ($m), 2002-2009 51

Table 33: Orthobiologics Market, India, Revenue ($m), 2009-2016 52

Table 34: Orthobiologics Market, Australia, Revenue ($m), 2002-2009 53

Table 35: Orthobiologics Market, Australia, Revenue ($m), 2009-2016 54

Table 36: Orthobiologics Market, Brazil, Revenue ($m), 2002-2009 55

Table 37: Orthobiologics Market, Brazil, Revenue ($m), 2009-2016 56

Table 38: Orthobiologics, Key Company Revenues ($m), Global 57

Table 39: Medtronic, Inc. , Marketed Products, 2010 58

Table 40: Medtronic, Pipeline Products, 2010 59

Table 41: Genzyme Corporation, Marketed Products, 2010 59

Table 42: Depuy, Marketed Products, 2010 60

Table 43: Depuy, Pipeline Products, 2010 60

Table 44: Synthes, Inc, Marketed Products, 2010 61

Table 45: Smith & Nephew, Marketed Products, 2010 62

Table 46: Smith & Nephew , Pipeline Products, 2010 62

Table 47: Stryker, Marketed Products, 2010 63

Table 48: Stryker , Pipeline Products, 2010 63

Table 49: Orthofix International, Marketed Products, 2010 64

Table 50: Orthofix International , Pipeline Products, 2010 64

Table 51: Infuse Bone Graft and the LT-Cage Device, Features and Benefits 65

Table 52: OP 1 Putty, Features and Benefits 65

Table 53: chronOS, Features and Benefits 66

Table 54: Healos Bone Graft Replacement, Features and Benefits 66

Table 55: Synvisc-one, Features and Benefits 66

Table 56: SUPARTZ, Features and Benefits 67

Table 57: Optium DBM, Features and Benefits 67

Table 58: DBX; Features and Benefits 67

Table 59: VIAGRAF, Features and Benefits 68

Table 60: Exogen, Features and Benefits 68

Table 61: Physio-Stim, Features and Benefits 68

Table 62: Allograft TLIF, Features and Benefits 69

Table 63: Allograft PL, Features and Benefits 69

Table 64: Trinity Evolution, Features and Benefits 69

Table 65: Pipeline Products, Orthobiologics, by Development Stage, Global, 2010 70

Table 66: Pipeline Products, Orthobiologics, by Segment, Global, 2010 71

Table 67: To Evaluate The Safety And Effectiveness Of GEM OS1 Compared To Autologous Bone Graft As A Bone Regeneration Device In Foot And Ankle Fusions 72

Table 68: The Efficacy Of rhBMP-2 For Posterolateral Lumbar Fusion In Smokers. 74

Table 69: Orthobiologics, Pipeline Products, BMP, 2010 78

Table 70: Orthobiologics, Pipeline Products, Bone Allografts, 2010 79

Table 71: Orthobiologics, Pipeline Products, Bone Graft Substitutes, 2010 79

Table 72: Orthobiologics, Pipeline Products, Bone Growth Stimulators, 2010 80

Table 73: Orthobiologics, Pipeline Products, DBM, 2010 80

Table 74: Orthobiologics, Pipeline Products, Synthetic Bone Graft Substitutes, 2010 81

Table 75: Orthobiologics, Pipeline Products, Viscosupplementation, 2010 82

Table 76: Orthobiologics, Pipeline Products, Others, 2010 82

Table 77: Orthobiologics, Pipeline Products, Others, 2010 83

Table 78: Orthobiologics, Pipeline Products, Others, 2010 84

Table 79: Orthobiologics Market, Key Deals, 2006–2010* 851.2

List of Figures

Figure 1: Orthobiologics, Market Segments, 2010 10

Figure 2: Orthobiologics Market, Global, Revenue ($m), 2002–2009 12

Figure 3: Orthobiologics Market, Global, Revenue ($m), 2009–2016 13

Figure 4: Orthobiologics Market, Drivers and Restraints 14

Figure 5: Bone Graft Substitutes Market, Global, Revenue ($m), 2002–2009 18

Figure 6: Bone Graft Substitutes Market, Global, Revenue ($m), 2009–2016 19

Figure 7: Viscosupplementation Market, Global, Revenue ($m), 2002–2009 21

Figure 8: Viscosupplementation Market, Global, Revenue ($m), 2009–2016 22

Figure 9: DBM Market, Global, Revenue ($m), 2002–2009 24

Figure 10: DBM Market, Global, Revenue ($m), 2009–2016 25

Figure 11: Bone Growth Stimulators Market, Global, Revenue ($m), 2002–2009 27

Figure 12: Bone Growth Stimulators Market, Global, Revenue ($m), 2009–2016 28

Figure 13: Bone Allografts Market, Global, Revenue ($m), 2002–2009 29

Figure 14: Bone Allografts Market, Global, Revenue ($m), 2009–2016 30

Figure 15: Orthobiologics Market, Global, Segment Analysis, 2002 – 2016 32

Figure 16: Orthobiologics Market, US, Revenue ($m), 2002-2009 33

Figure 17: Orthobiologics Market, US, Revenue ($m), 2009-2016 34

Figure 18: Orthobiologics Market, Canada, Revenue ($m), 2002-2009 35

Figure 19: Orthobiologics Market, Canada, Revenue ($m), 2009-2016 36

Figure 20: Orthobiologics Market, Germany, Revenue ($m), 2002-2009 37

Figure 21 Orthobiologics Market, Germany, Revenue ($m), 2009-2016 38

Figure 22: Orthobiologics Market, UK, Revenue ($m), 2002-2009 39

Figure 23: Orthobiologics Market, UK, Revenue ($m), 2009-2016 40

Figure 24: Orthobiologics Market, France, Revenue ($m), 2002-2009 41

Figure 25: Orthobiologics Market, France, Revenue ($m), 2009-2016 42

Figure 26: Orthobiologics Market, Spain, Revenue ($m), 2002-2009 43

Figure 27: Orthobiologics Market, Spain, Revenue ($m), 2009-2016 44

Figure 28: Orthobiologics Market, Italy, Revenue ($m), 2002-2009 45

Figure 29: Orthobiologics Market, Italy, Revenue ($m), 2009-2016 46

Figure 30: Orthobiologics Market, Japan, Revenue ($m), 2002-2009 47

Figure 31: Orthobiologics Market, Japan, Revenue ($m), 2009-2016 48

Figure 32: Orthobiologics Market, China, Revenue ($m), 2002-2009 49

Figure 33: Orthobiologics Market, China, Revenue ($m), 2009-2016 50

Figure 34: Orthobiologics Market, India, Revenue ($m), 2002-2009 51

Figure 35: Orthobiologics Market, India, Revenue ($m), 2009-2016 52

Figure 36: Orthobiologics Market, Australia, Revenue ($m), 2002-2009 53

Figure 37: Orthobiologics Market, Australia, Revenue ($m), 2009-2016 54

Figure 38: Orthobiologics Market, Brazil, Revenue ($m), 2002-2009 55

Figure 39: Orthobiologics Market, Brazil, Revenue ($m), 2009-2016 56

Figure 40: Orthobiologics Market, Global, Company Shares (% Revenue), 2009 57

Figure 41: Medtronic, Inc. , Pipeline Products, 2010 59

Figure 42: Depuy, Pipeline Products, 2010 60

Figure 43: Smith & Nephew , Pipeline Products, 2010 62

Figure 44: Stryker , Pipeline Products, 2010 63

Figure 45: Orthofix International , Pipeline Products, 2010 64

Figure 46: Pipeline Products, Orthobiologics, by Development Stage, Global, 2010 70

Figure 47: Pipeline Products, Orthobiologics, by Segment, Global, 2010 71

Figure 48: Orthobiologics Market Deal Analysis, Value ($m) and Volume, 2006–2010* 85

Companies mentioned

Medtronic Inc.

Genzyme Corporation

Depuy, Inc.(Johnson & Johnson)

Synthes, Inc.

Smith & Nephew Plc

Stryker

Orthofix International N.V

To order this report:

Orthopedic Industry: Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Orthopedic Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!


CONTACT:  

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626




SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com